Loading...
News2020-05-06T12:01:25-06:00

Categories

Archives

PRESS RELEASE: IVI Selects Pharmerit to Construct Foundation of Major Depressive Disorder Value Assessment Model

Health Economics Experts to Work with IVI-convened Advisory Group to Assess and Determine Model Inputs October 20, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI)— a nonprofit organization dedicated to advancing the [...]

October 20th, 2020|IVI News, Press|

PRESS RELEASE: IVI’s Next Value Assessment Model to Address Major Depressive Disorder Interventions

First of Its Kind Depression Model to be Informed by Input from Diverse Advisory Group September 9, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI) — a non-profit organization dedicated to advancing [...]

September 9th, 2020|IVI News, Press|

IVI and the University of Maryland Pharmacy School’s PAVE Center Partner on Patient-Centered Value Assessment

In an article in The Patient, IVI and the Patient-Driven Values in Healthcare Evaluation (PAVE) Center at the University of Maryland School of Pharmacy describe how they develop methods and models that make patient-centered value [...]

August 28th, 2020|IVI News, Viewpoints|

Second Webinar in the ISPOR-IVI Series Explores Whether Value Assessments are Up to the Task in the Age of COVID-19

The second part of a five-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have [...]

August 24th, 2020|IVI News|

BLOG: Exploring Patient Heterogeneity and Diversity in Treatment Responses

Author: Jennifer Bright, MPA Everyone hopes for a COVID vaccine so our lives can return to normal. Yet, we know that even if clinical trials prove a vaccine's effectiveness, our society will still have to [...]

August 20th, 2020|Blog|

Jennifer Bright Discusses Her Journey and How to Improve Value Assessment

In an interview with Dr. William Seeds in Authority Magazine, Jennifer Bright talks about her own journey to IVI, what drives her to improve value assessment, and why collaboration is paramount for success. Read the [...]

July 30th, 2020|IVI News|

The Promise of MCDA to Improve Equity in Value Assessment

In a commentary in AJMC, IVI examines how multi-criteria decision analysis has the potential to better understand and assess value for innovative cell and gene therapies which are transforming the lives of patients living with [...]

July 26th, 2020|IVI News, Viewpoints|

BLOG: How do we identify and measure value for patients with rare diseases?

Authors: Annie Kennedy and Joff Masukawa. Rare diseases impact 1 in 10 Americans, and over 400 million people worldwide. The current development and FDA approval process can cost hundreds of millions of dollars – and [...]

July 22nd, 2020|Blog|
Go to Top